Drug delivery from structured porous inorganic materials.
about
Sodium montmorillonite/amine-containing drugs complexes: new insights on intercalated drugs arrangement into layered carrier materialDrug-targeting methodologies with applications: A reviewMolecular recognition by gold, silver and copper nanoparticles.Recent advances of cocktail chemotherapy by combination drug delivery systems.Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: evaluation of their safety and biocompatibility.Comparative Kinetic Analysis of Closed-Ended and Open-Ended Porous Sensors.Lanthanide-doped hollow nanomaterials as theranostic agents.Implementing tissue engineering and regenerative medicine solutions in medical implants.Prolonged Dye Release from Mesoporous Silica-Based Imaging Probes Facilitates Long-Term Optical Tracking of Cell Populations In Vivo.Untethered magnetic millirobot for targeted drug delivery.Correlation of the intracellular reactive oxygen species levels with textural properties of functionalized mesostructured silica.Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.Polymeric micelles for multidrug delivery and combination therapy.Modulation of microporous/mesoporous structures in self-templated cobalt-silica.Replenishable dendrimer-nanoparticle hybrid membranes for sustained release of therapeutics.3D Printed Auxetic Mechanical Metamaterial with Chiral Cells and Re-entrant Cores.Macromolecule loading into spherical, elliptical, star-like and cubic calcium carbonate carriers.Factors affecting drug adsorption on beta zeolites
P2860
Q28544966-CB08022A-7F94-4038-945F-2AC69D66E557Q28649786-C47C33F6-EFEE-4925-9861-D8F630C05DBDQ30450339-486C5F8C-143B-479E-AF40-008246FE87B9Q37206908-4A9DB216-9F88-4D8E-BBE3-5D184962458DQ37233323-93C69F55-8B25-4A1C-8A18-CED1A4CFA2D1Q37250232-02354800-F1B4-4BF2-9BA1-9FD6139E3368Q38162427-2BB09E7E-A912-4157-A6C6-93DCD75C2DA9Q38172911-7A2D23DF-2D72-4C9D-B024-2CD059E39DF0Q38799690-34ECA16E-E4A8-467E-AD22-92BF51C26F5FQ38871046-BFF635B5-AB44-41D2-96EE-C1A9C8768FA1Q39010664-6D8FC3A7-E0C9-4F91-AC64-EB9E78763C20Q39081912-A32C6AEB-8540-40A2-98C6-A1BDCF013B2CQ39367399-1AF653ED-2085-4A7F-865D-54A07BB83284Q41841749-95D933FD-10E7-4FD3-9CB4-5849656F0192Q42071872-00EFFEC0-AA67-4588-A422-C23DD6A23E23Q49704734-3730BC9D-C032-4705-8EFE-B48A64A56C1FQ54184603-B01EFDDF-03DB-4D75-9E66-14F81CF54BD3Q58499718-C48A08FD-1B90-4232-A090-3D623C0FD630
P2860
Drug delivery from structured porous inorganic materials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug delivery from structured porous inorganic materials.
@en
Drug delivery from structured porous inorganic materials.
@nl
type
label
Drug delivery from structured porous inorganic materials.
@en
Drug delivery from structured porous inorganic materials.
@nl
prefLabel
Drug delivery from structured porous inorganic materials.
@en
Drug delivery from structured porous inorganic materials.
@nl
P2860
P356
P1476
Drug delivery from structured porous inorganic materials.
@en
P2093
Manuel Arruebo
P2860
P356
10.1002/WNAN.132
P577
2011-03-03T00:00:00Z